Jeffrey Cram
About Jeffrey Cram
Jeffrey Cram is a Senior Director of Cellular Process Development at ElevateBio, where he has worked since 2022. He has extensive experience in the biotechnology field, having held various positions at companies such as bluebird bio and Dana-Farber Cancer Institute.
Current Role at ElevateBio
Jeffrey Cram serves as the Senior Director of Cellular Process Development at ElevateBio, a position he has held since 2022. In this role, he oversees the development and optimization of cellular processes, contributing to the company's advancements in cell and gene therapies. Prior to this, he was the Associate Director at ElevateBio from 2019 to 2020, where he gained experience in cellular process development within the biotechnology sector.
Previous Experience in Biotechnology
Cram has a diverse background in the biotechnology field. He worked at bluebird bio as a Senior Scientist from 2016 to 2019, and previously as Scientist II from 2014 to 2019. His experience also includes a role as Project Leader II at Dana-Farber Cancer Institute from 2012 to 2014, and as a Technologist in Cellular Therapy from 2004 to 2012. Earlier in his career, he served as a Laboratory Coordinator at AVANT Immunotherapeutics from 2001 to 2002.
Educational Background
Jeffrey Cram earned his Bachelor’s degree in Biology from Worcester State University, where he studied from 1998 to 2002. He furthered his education at Northeastern University, completing a program in Project Management from 2012 to 2014. This educational foundation supports his expertise in cellular process development and project management within the biotechnology industry.
Work History Overview
Cram's professional journey spans over two decades in the life sciences and biotechnology sectors. His roles have included significant positions at prominent organizations such as Dana-Farber Cancer Institute, bluebird bio, and ElevateBio. His career reflects a steady progression in responsibilities, culminating in his current leadership role in cellular process development.